Offer - Urjas Oil for just ₹ 1
Ibiflo 125 Nexhaler is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Ibiflo 125 Nexhaler safe for pregnant women?
Ibiflo may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Ibiflo again without your doctor's advice.
Is the use of Ibiflo 125 Nexhaler safe during breastfeeding?
There is no research available on the side effects of Ibiflo in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Ibiflo 125 Nexhaler on the Kidneys?
Ibiflo has very mild side effects on the kidneys.
What is the effect of Ibiflo 125 Nexhaler on the Liver?
Ibiflo may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Ibiflo 125 Nexhaler on the Heart?
You may experience side effects on your heart after taking Ibiflo. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Ibiflo 125 Nexhaler unless your doctor advises you to do so -
Is this Ibiflo 125 Nexhaler habit forming or addictive?
Ibiflo 125 Nexhaler does not cause addiction.
Interaction between Food and Ibiflo 125 Nexhaler
Due to a lack of research, nothing can be said about the consequences of taking Ibiflo 125 Nexhaler together with food.
Interaction between Alcohol and Ibiflo 125 Nexhaler
Information about the interaction of Ibiflo 125 Nexhaler and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596